子宫肌瘤中色氨酸分解代谢失调
实验研究比较了子宫肌瘤与配对肌层组织中IDO1和TDO2的表达及功能。肌瘤中IDO1和TDO2的mRNA、蛋白及犬尿氨酸水平显著升高;TDO2抑制剂680C91而非IDO1抑制剂epacadostat可剂量依赖性抑制平滑肌细胞增殖及I/III型胶原表达,且在肌瘤细胞中更明显。
要点
- 子宫肌瘤中IDO1和TDO2的mRNA、蛋白及酶活性标志物犬尿氨酸显著高于配对肌层组织。
- TDO2在MED12突变肌瘤中表达更高,且非裔美国患者TDO2 mRNA高于白人和西班牙裔。
- TDO2抑制剂680C91可抑制肌瘤平滑肌细胞增殖及COL1A1、COL3A1表达。
核心结论
- 色氨酸降解通路在子宫肌瘤发病机制中具有生理意义,抗TDO2药物可能用于治疗子宫肌瘤。
研究设计与样本
- 实验研究,纳入因子宫肌瘤行子宫切除术的女性,检测肌瘤与配对肌层组织中IDO1和TDO2表达,并用抑制剂处理平滑肌细胞球状体。
主要发现
- 肌瘤中IDO1 mRNA升高60.3%(35/58对),TDO2 mRNA升高98.3%(57/58对)。
- 肌瘤中IDO1蛋白升高54%(27/50对),TDO2蛋白升高92%(46/50对)。
- 犬尿氨酸(IDO1/TDO2酶活性标志物)在78.3%(36/46对)的肌瘤中升高。
- TDO2而非IDO1 mRNA在非裔美国患者肌瘤中显著高于白人和西班牙裔患者。
- TDO2而非IDO1的mRNA和蛋白在携带MED12突变的肌瘤中高于野生型肌瘤。
关键数值与推荐
- TDO2抑制剂680C91而非IDO1抑制剂epacadostat剂量依赖性抑制肌瘤和肌层平滑肌细胞球状体增殖及COL1A1、COL3A1表达,对肌瘤细胞作用更明显。
临床怎么用
- 提示TDO2可作为子宫肌瘤潜在治疗靶点,但尚需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the expression and functional roles of indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO2) in leiomyoma. DESIGN: Experimental study. SETTING: Academic research laboratory. PATIENT(S): Women undergoing hysterectomy for leiomyoma. INTERVENTION(S): Blockade of IDO1 and TDO2. MAIN OUTCOME MEASURE(S): Expression of IDO1 and TDO2 in leiomyoma and the effects of their inhibitors on the extracellular matrix. RESULT(S): Leiomyoma expressed significantly higher levels of IDO1 and TDO2 messenger ribonucleic acid (mRNA; 60.3%, 35/58 pairs and 98.3%, 57/58 pairs, respectively) and protein (54%, 27/50 pairs and 92%, 46/50 pairs, respectively) as well as the enzyme activity marker kynurenine (78.3%, 36/46 pairs for IDO1/TDO2) compared with levels in matched myometrium. The expression of TDO2 but not IDO1 mRNA was significantly higher in fibroids from African American compared with that in Caucasian and Hispanic patients. The TDO2 but not the IDO1 protein and mRNA levels were more abundant in fibroids bearing the MED12 mutation compared with results in wild-type leiomyomas. Treatment of leiomyoma smooth muscle cell and myometrial smooth muscle cell spheroids with the TDO2 inhibitor 680C91 but not the IDO1 inhibitor epacadostat significantly repressed cell proliferation and the expression of collagen type I (COL1A1) and type III (COL3A1) in a dose-dependent manner; these effects were more pronounced in leiomyoma smooth muscle cells compared with myometrial smooth muscle cell spheroids. CONCLUSION(S): These results underscore the physiological significance of the tryptophan degradation pathway in the pathogenesis of leiomyomas and the potential utility of anti-TDO2 drugs for treatment of leiomyomas.
引用
- Chuang TD, Quintanilla D, Boos D, et al. Tryptophan catabolism is dysregulated in leiomyomas. Fertil Steril. 2021. PMID: 34116832. doi:10.1016/j.fertnstert.2021.05.081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。